Friday, February 27, 2015 7:19:50 AM
i very quickly read some of the posts regarding the loan and they seemed to be of a positive note. Did I read wrong, or did musclepharm give over 800 000 shares to abn just for doing the loan. that would mean it cost shareholders 6 million in equity just for loan approval which is interest bearing. you would assume if everything was on the up and up, they could have sold the 800 000 shares in an equity offering (which would have the same resulting dilution at the loan) and put cash into the company as opposed to debt. At first I thought the shares were just issued as security, but it appears thats not the case, and not only were the shares issued but they also took security on the entire assets of the company. I would have lent them the money if I was getting 1.5X my loan value in shares immediately!
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM